Biotechnology Assets S.A. Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2022
2021
2020
2019
3M
-15.28%
0M
3M
4M
1M
0M
2M
0M
-2M
0M
-2M
-35.50%
4M
0M
213M
0M
-2M
3M
22.21%
0M
3M
5M
1M
0M
-2M
1M
-3M
0M
-3M
-64.99%
5M
0M
0M
0M
-2M
3M
-93.96%
0M
3M
4M
0M
0M
-1M
0M
-2M
0M
-9M
-14.64%
4M
0M
1M
0M
-1M
42M
-
16M
26M
32M
4M
0M
-7M
3M
-10M
0M
-10M
-14.64%
47M
0M
-1M
0M
-6M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT